OLAITAN ADESOLA EBODA

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health CHERRY HILL, NJ NPI 1114652138

General Payments — all program years on this page

$1,299.40

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 70
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $541.27 across 37 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $541.2737

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $256.0020
Otsuka America Pharmaceutical, Inc. $143.659
ITI, Inc. $87.255
Lundbeck LLC $19.991
Teva Pharmaceuticals USA, Inc. $17.581
E.R. Squibb & Sons, L.L.C. $16.801

By program year

Program yearAmountRecords
2023 $758.1333
2024 $541.2737

Records — PY2024 (37)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101567936 E.R. Squibb & Sons, L.L.C. $16.80 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674545 ABBVIE INC. $10.24 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674547 ABBVIE INC. $9.91 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674549 ABBVIE INC. $14.59 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674551 ABBVIE INC. $11.01 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674553 ABBVIE INC. $17.87 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674555 ABBVIE INC. $16.14 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674557 ABBVIE INC. $10.75 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674559 ABBVIE INC. $13.02 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674561 ABBVIE INC. $12.39 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674563 ABBVIE INC. $13.09 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674565 ABBVIE INC. $11.05 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674567 ABBVIE INC. $12.69 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674569 ABBVIE INC. $12.84 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674571 ABBVIE INC. $11.24 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674573 ABBVIE INC. $7.27 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674575 ABBVIE INC. $5.93 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674577 ABBVIE INC. $12.08 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674579 ABBVIE INC. $17.26 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674581 ABBVIE INC. $17.80 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103674583 ABBVIE INC. $18.83 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119064044 Otsuka America Pharmaceutical, Inc. $17.94 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119064046 Otsuka America Pharmaceutical, Inc. $16.52 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119064048 Otsuka America Pharmaceutical, Inc. $15.96 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119064050 Otsuka America Pharmaceutical, Inc. $16.72 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119064052 Otsuka America Pharmaceutical, Inc. $12.55 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119064054 Otsuka America Pharmaceutical, Inc. $14.92 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119064056 Otsuka America Pharmaceutical, Inc. $16.05 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119064058 Otsuka America Pharmaceutical, Inc. $18.33 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119064060 Otsuka America Pharmaceutical, Inc. $14.66 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143436547 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.47 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143436551 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.78 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143436554 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.92 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143436558 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.89 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143436562 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.19 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146017090 Lundbeck LLC $19.99 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151568043 Teva Pharmaceuticals USA, Inc. $17.58 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.